These findings demonstrate that CHBP attenuates renal fibrosis and the epithelial-mesenchymal transition of tubular cells, possibly through suppression of the PI3K/Akt pathwayand thereby the inhibition FoxO3a activity. The gene discussed is AKT1; the disease is renal fibrosis.